文献速递白血病造血干细胞移植与细胞治疗

病例报告:女性患者接受男性同胞异基因移植后发生罕见的供者细胞来源T细胞急性淋巴细胞白血病

Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.
PubMed 文献 · Br J Haematol · 2023-07-31

本文报告一例罕见的供者细胞来源T细胞急性淋巴细胞白血病,患者为接受男性同胞异基因移植的女性,疾病潜伏期不足4年。基因组和体外分析发现NOTCH1新突变及STAT5B新激活突变,后者可被临床可用药物维奈克拉和芦可替尼靶向。

要点

  • 供者细胞来源血液肿瘤可表现为T细胞急性淋巴细胞白血病,潜伏期不足4年。
  • 基因组分析发现NOTCH1新突变和STAT5B新激活突变。
  • STAT5B激活突变可被维奈克拉和芦可替尼靶向。

核心结论

  • 报告一例供者细胞来源T细胞急性淋巴细胞白血病,潜伏期不足4年,发现NOTCH1新突变及STAT5B新激活突变,后者可被维奈克拉和芦可替尼靶向。

研究设计与样本

  • 病例报告,对一例接受男性同胞异基因移植的女性患者进行基因组和体外分析。

主要发现

  • 患者发生供者细胞来源T细胞急性淋巴细胞白血病,疾病潜伏期不足4年。
  • 基因组分析发现NOTCH1新突变以及STAT5B新激活突变。
  • 体外分析显示STAT5B激活突变可被维奈克拉和芦可替尼靶向。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Donor-derived haematological neoplasms, in which recipients present with haematological malignancies that have evolved from transplant donor stem cells, have previously been described for myelodysplastic syndrome, myeloproliferative neoplasms, acute myeloid leukaemia and less often, leukaemias of lymphoid origin. Here we describe a rare and complex case of donor-derived T-cell acute lymphoblastic leukaemia with a relatively short disease latency of less than 4 years. Through genomic and in vitro analyses, we identified novel mutations in NOTCH1 as well as a novel activating mutation in STAT5B; the latter targetable with the clinically available drugs, venetoclax and ruxolitinib.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Eadie LN, Rehn JA, Schutz CE, et al. Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling. Br J Haematol. 2023. PMID: 37519213. doi:10.1111/bjh.19008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。